Mechanisms of BCG immunotherapy and its outlook for bladder cancer

@article{Pettenati2018MechanismsOB,
  title={Mechanisms of BCG immunotherapy and its outlook for bladder cancer},
  author={C. Pettenati and M. Ingersoll},
  journal={Nature Reviews Urology},
  year={2018},
  volume={15},
  pages={615-625}
}
  • C. Pettenati, M. Ingersoll
  • Published 2018
  • Medicine
  • Nature Reviews Urology
    • BCG immunotherapy is the gold-standard treatment for non-muscle-invasive bladder cancer at high risk of recurrence or progression. Preclinical and clinical studies have revealed that a robust inflammatory response to BCG involves several steps: attachment of BCG; internalization of BCG into resident immune cells, normal cells, and tumour urothelial cells; BCG-mediated induction of innate immunity, which is orchestrated by a cellular and cytokine milieu; and BCG-mediated initiation of tumour… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    80 Citations
    Highly Influential Citations
    5
    Background Citations
    34
    Methods Citations
    6
    Results Citations
    1
    80 Citations
    Citation Type

    Citation Type

    Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer
    • 2
    Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect.
    • 1
    Bacillus Calmette–Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections
    • 9
    Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
    • 13
    Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
    • 16
    • PDF
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling
    • 3
    Recombinant BCG overexpressing a STING agonist elicits trained immunity and improved antitumor efficacy in non-muscle invasive bladder cancer
    • PDF
    Mechanisms of immune evasion in bladder cancer
    • 16
    • PDF
    In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment
    • 6
    • PDF
    Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives
    • 9
    • PDF

    References

    SHOWING 1-10 OF 208 REFERENCES
    Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
    • 110
    • PDF
    Role of neutrophils in BCG immunotherapy for bladder cancer.
    • 99
    Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
    • 51
    • PDF
    [Mechanisms of action of BCG: towards a new individualized therapeutic approach?].
    • F. Saint, J. J. Patard, +4 authors D. Chopin
    • Medicine
    • Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
    • 2000
    • 2
    Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.
    • 266
    BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines.
    • 43
    T-cell subsets required for intravesical BCG immunotherapy for bladder cancer.
    • 223
    Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer
    • 7
    Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells.
    • 78
    NK cells are essential for effective BCG immunotherapy
    • 169